198 related articles for article (PubMed ID: 17401084)
1. Somatostatin receptor imaging in patients with neuroendocrine tumors: not only SPECT?
Schillaci O
J Nucl Med; 2007 Apr; 48(4):498-500. PubMed ID: 17401084
[No Abstract] [Full Text] [Related]
2. PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature.
Johnbeck CB; Knigge U; Kjær A
Future Oncol; 2014 Nov; 10(14):2259-77. PubMed ID: 25471038
[TBL] [Abstract][Full Text] [Related]
3. Diagnostics of neuroendocrine tumours.
Hodolic M; Fettich J; Banti E; Chondrogiannis S; Al-Nahhas A; Rubello D
In Vivo; 2010; 24(5):771-4. PubMed ID: 20952747
[TBL] [Abstract][Full Text] [Related]
4. [Radionuclide imaging of neurendocrine tumors: biological basis and diagnostic results].
Genovese EA; Mallardo V; Rossi M; Vaccaro A; Raucci A; Della Vecchi N; Romano G; Califano T; Schillirò F
Recenti Prog Med; 2013; 104(7-8):340-4. PubMed ID: 24042404
[TBL] [Abstract][Full Text] [Related]
5. Single-photon emission computed tomography tracers in the diagnostics of neuroendocrine tumors.
Pepe G; Bombardieri E; Lorenzoni A; Chiti A
PET Clin; 2014 Jan; 9(1):11-26. PubMed ID: 25029930
[TBL] [Abstract][Full Text] [Related]
6. Significance of a Single-Time-Point Somatostatin Receptor SPECT/Multiphase CT Protocol in the Diagnostic Work-up of Gastroenteropancreatic Neuroendocrine Neoplasms.
Ruf J; von Wedel F; Furth C; Denecke T; Stelter L; Steffen IG; Schütte K; Arend J; Ulrich G; Klose S; Bornschein J; Apostolova I; Amthauer H
J Nucl Med; 2016 Feb; 57(2):180-5. PubMed ID: 26609177
[TBL] [Abstract][Full Text] [Related]
7. Radio-guided surgery in neuroendocrine tumors.
Gulec SA; Baum R
J Surg Oncol; 2007 Sep; 96(4):309-15. PubMed ID: 17726664
[TBL] [Abstract][Full Text] [Related]
8. PET Imaging of Neuroendocrine Tumors.
Galgano SJ; Wei B; Rose JB
Radiol Clin North Am; 2021 Sep; 59(5):789-799. PubMed ID: 34392919
[No Abstract] [Full Text] [Related]
9. Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours.
Chiti A; Fanti S; Savelli G; Romeo A; Bellanova B; Rodari M; van Graafeiland BJ; Monetti N; Bombardieri E
Eur J Nucl Med; 1998 Oct; 25(10):1396-403. PubMed ID: 9818279
[TBL] [Abstract][Full Text] [Related]
10. Visualization of tumor heterogeneity in neuroendocrine tumors by positron emission tomography.
Lapa C; Werner RA; Herrmann K
Endocrine; 2016 Mar; 51(3):556-7. PubMed ID: 26084261
[No Abstract] [Full Text] [Related]
11. Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors.
Hope TA; Bergsland EK; Bozkurt MF; Graham M; Heaney AP; Herrmann K; Howe JR; Kulke MH; Kunz PL; Mailman J; May L; Metz DC; Millo C; O'Dorisio S; Reidy-Lagunes DL; Soulen MC; Strosberg JR
J Nucl Med; 2018 Jan; 59(1):66-74. PubMed ID: 29025982
[No Abstract] [Full Text] [Related]
12. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.
Schillaci O; Spanu A; Scopinaro F; Falchi A; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
J Nucl Med; 2003 Mar; 44(3):359-68. PubMed ID: 12621001
[TBL] [Abstract][Full Text] [Related]
13. Application and Dosimetric Requirements for Gallium-68-labeled Somatostatin Analogues in Targeted Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors.
Taïeb D; Garrigue P; Bardiès M; Abdullah AE; Pacak K
PET Clin; 2015 Oct; 10(4):477-86. PubMed ID: 26384594
[TBL] [Abstract][Full Text] [Related]
14. Radiolabeled bicyclic somatostatin-based analogs: a novel class of potential radiotracers for SPECT/PET of neuroendocrine tumors.
Fani M; Mueller A; Tamma ML; Nicolas G; Rink HR; Cescato R; Reubi JC; Maecke HR
J Nucl Med; 2010 Nov; 51(11):1771-9. PubMed ID: 20956465
[TBL] [Abstract][Full Text] [Related]
15. Preclinical studies of SPECT and PET tracers for NET.
Brom M; Boerman O; Gotthardt M; Oyen WJ
PET Clin; 2014 Jan; 9(1):63-9. PubMed ID: 25029935
[TBL] [Abstract][Full Text] [Related]
16. Molecular imaging of gastroenteropancreatic neuroendocrine tumors.
Miederer M; Weber MM; Fottner C
Gastroenterol Clin North Am; 2010 Dec; 39(4):923-35. PubMed ID: 21093764
[TBL] [Abstract][Full Text] [Related]
17. [Imaging and radioguided surgery of tumors NETs].
Schillirò F; Mallardo V; Manna A; Fontanarosa A; Califano T; Della Vecchia N; Romano G; Di Crescenzo V; Genovese EA
Recenti Prog Med; 2013; 104(7-8):336-9. PubMed ID: 24042403
[TBL] [Abstract][Full Text] [Related]
18. Exceptional increase in somatostatin receptor expression in pancreatic neuroendocrine tumour, visualised with (68)Ga-DOTATOC PET.
Henze M; Schuhmacher J; Dimitrakopoulou-Strauss A; Strauss LG; Mäcke HR; Eisenhut M; Haberkorn U
Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):466. PubMed ID: 14730407
[No Abstract] [Full Text] [Related]
19. Masking effect of chronic pancreatitis in the interpretation of somatostatin receptor positron emission tomography in pancreatic neuroendocrine tumors.
Treglia G; Farchione A; Stefanelli A; Brizi MG; Larghi A; Inzani F; Rindi G; Rufini V
Pancreas; 2013 May; 42(4):726-8. PubMed ID: 23591437
[No Abstract] [Full Text] [Related]
20. Somatostatin receptor SPECT.
Pepe G; Moncayo R; Bombardieri E; Chiti A
Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S41-51. PubMed ID: 22388628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]